|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,860.00 KRW | +1.25% |
|
+10.08% | -28.74% |
| 09/12 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/25/12 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Business description: GC Genome Corporation

Executive Committee: GC Genome Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Chang-Seok Gi
CEO | Chief Executive Officer | 57 | 26/03/2020 |
Sang-Hun Jeong
DFI | Director of Finance/CFO | 50 | 27/03/2025 |
Seu-Nga Hyun
AUD | Comptroller/Controller/Auditor | 45 | 29/03/2024 |
Eun-Hae Jo
PRN | Corporate Officer/Principal | 52 | - |
Composition of the Board of Directors: GC Genome Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Sang-Uk Kim
BRD | Director/Board Member | 57 | 30/03/2023 |
Company details: GC Genome Corporation

Medical & Diagnostic Laboratories
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.25% | +10.08% | -46.00% | - | 7.42Cr | ||
| +0.86% | +3.79% | +78.11% | +500.08% | 4TCr | ||
| -0.66% | +2.09% | +10.69% | +36.27% | 2.35TCr | ||
| +1.36% | +5.48% | -20.69% | -38.88% | 728.15Cr | ||
| +1.69% | +18.42% | +27.04% | +129.49% | 540.61Cr | ||
| +2.45% | -0.19% | +18.36% | +47.28% | 288.75Cr | ||
| +1.76% | -1.24% | -20.38% | +1,134.45% | 200.42Cr | ||
| +0.69% | +7.44% | +109.44% | +1.06% | 197.4Cr | ||
| -3.96% | +2.81% | +33.01% | -23.57% | 182.04Cr | ||
| +2.21% | +0.96% | +21.00% | -2.54% | 165.17Cr | ||
| Average | +0.77% | +4.29% | +21.06% | +198.18% | 866.35Cr | |
| Weighted average by Cap. | +0.60% | +6.85% | +42.61% | +273.11% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- A340450 Stock
- Company GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions

















